Calumet, Inc. (CLMT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Calumet, Inc. (CLMT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Bet_Noire/iStock via Getty Images Many Bitcoin Bulls at this point in the game are institutional investors moving into the world’s most popular cryptocurrency, as retail investors abandon their positions due to a rash of margin calls. In January, Strategy bought $2.13 billion of bitcoin in just eight days, bringing its holdings at that time to 709,715 BTC; by March 29, Strategy said in an SEC fili...
Bet_Noire/iStock via Getty Images Many Bitcoin Bulls at this point in the game are institutional investors moving into the world’s most popular cryptocurrency, as retail investors abandon their positions due to a rash of margin calls. In January, Strategy bought $2.13 billion of bitcoin in just eight days, bringing its holdings at that time to 709,715 BTC; by March 29, Strategy said in an SEC filing that its total had risen to about 762,099 BTC. While Strategy holds the largest Bitcoin stash of any company in the world, it is not alone in following a business model of Bitcoin accumulation. MARA Holdings (MARA), Twenty One Capital (XXI), Tesla, Inc. (TSLA), and Block, Inc. (XYZ) have also purchased substantial amounts of Bitcoin, sometimes as an investment, sometimes as a hedge against inflation. Riot Platforms and Coinbase also hold significant amounts to support their cryptocurrency operations. Looking at a recent Bitcoin chart, we can easily see the classic head-and-shoulders formation as well as a death cross, both of which indicate a downward trend. Finance.Yahoo.com Fig. 1 While many Bitcoin Bulls maintain that a surge of corporate investors into the Bitcoin space creates a floor beneath the world’s most popular cryptocurrency, Bitcoin’s institutional support is hardly risk-free. The floor provided by the numerous corporations flocking into Bitcoin is built on a shaky foundation that may be cracking under the pressure of global events. Even before the Iran war sent oil prices soaring, the macro backdrop for the entire equities market was already fragile. Bitcoin’s New Institutional Floor Could Become a Trap Door Taking a closer look at the mosaic tiles that make up the institutional flooring beneath the current price of Bitcoin, what we see is a complex pattern of stock issuance, corporate bonds, and even Bitcoin holdings being used as collateral to buy more Bitcoins. The most common ways that institutional investors raise money to purchase large amounts of Bit...
Microsoft is on track to invest $5.5 billion in cloud and artificial intelligence infrastructure in Singapore through 2029, the Wall Street Journal reported on Wednesday. Microsoft did not immediately respond to a Reuters request for comment. (Reporting by Anusha Shah in Bengaluru; Editing by Janane Venkatraman)
Microsoft is on track to invest $5.5 billion in cloud and artificial intelligence infrastructure in Singapore through 2029, the Wall Street Journal reported on Wednesday. Microsoft did not immediately respond to a Reuters request for comment. (Reporting by Anusha Shah in Bengaluru; Editing by Janane Venkatraman)
The S&P Global France Manufacturing Purchasing Managers’ Index posted 50.0 in March,marking little change from February's 50.1 and therefore signalling stagnant operating conditions across France's goods-producing economy. The figure was lower than estimated 50.2. "The March PMI revealed an immediate impact from the war in the Middle East. The survey data, collected between 12-24 March, imply a ra...
The S&P Global France Manufacturing Purchasing Managers’ Index posted 50.0 in March,marking little change from February's 50.1 and therefore signalling stagnant operating conditions across France's goods-producing economy. The figure was lower than estimated 50.2. "The March PMI revealed an immediate impact from the war in the Middle East. The survey data, collected between 12-24 March, imply a rapid supply-side squeeze from the conflict as delivery times lengthened substantially and input costs soared. The passthrough to output prices appears to be fairly contained at this stage. This could be due to an unfavourable demand environment limiting French producers' pricing power, although firms may also be stalling price increases in the hope that there is a quick resolution to the war that brings with it a normalisation of supply and price conditions." said Joe Hayes, Principal Economist at S&P Global Market Intelligence. More on France U.S. Tariffs: A New Trade War? EWQ: Falling Real Rates Delayed The Bear Case, But 2026 May Not ‘Mr. Brexit’ strategist nails winning calls as Iran conflict erupts Euro Area inflation rises to 2.5% in March Seeking Alpha’s Quant Rating on iShares MSCI France ETF
Nvidia (NASDAQ: NVDA) has been one of the best-performing stocks in the market for the past five years, up 1,220% over that period. That has helped it grow to become the largest company in the world , with a market capitalization (market cap) of over $4.1 trillion. Nvidia's rise to the mountaintop is well deserved. The company has just seen explosive growth over the past several years. Its revenue...
Nvidia (NASDAQ: NVDA) has been one of the best-performing stocks in the market for the past five years, up 1,220% over that period. That has helped it grow to become the largest company in the world , with a market capitalization (market cap) of over $4.1 trillion. Nvidia's rise to the mountaintop is well deserved. The company has just seen explosive growth over the past several years. Its revenue has gone from $16.7 billion in fiscal 2021 (ending January 2022) to $215.9 billion last fiscal year. That's nearly a 13 times increase in revenue in just five years. However, it is how the company has been able to evolve over the years that makes its stock a buy today. Image source: The Motley Fool. Continue reading
When gas prices rise, it isn't just oil companies that benefit. Costco and BJ's both benefit from high fuel prices, and their stocks look poised for growth.
When gas prices rise, it isn't just oil companies that benefit. Costco and BJ's both benefit from high fuel prices, and their stocks look poised for growth.
Earnings Call Insights: Omeros Corporation (OMER) Q4 2025 Management View "Two major successes made the fourth quarter of 2025 a turning point for Omeros." (Co-Founder, Chairman, CEO & President Gregory Demopulos) "On November 25, we closed our previously announced asset purchase and license transaction with Novo Nordisk for our Phase III ready asset, zaltenibart." (CEO Demopulos) He said the deal...
Earnings Call Insights: Omeros Corporation (OMER) Q4 2025 Management View "Two major successes made the fourth quarter of 2025 a turning point for Omeros." (Co-Founder, Chairman, CEO & President Gregory Demopulos) "On November 25, we closed our previously announced asset purchase and license transaction with Novo Nordisk for our Phase III ready asset, zaltenibart." (CEO Demopulos) He said the deal brought "$240 million" upfront, plus "$100 million in achievable near-term milestones," and additional milestones and royalties, adding, "All told, the deal is valued at up to $2.1 billion in upfront and milestone payments." (CEO Demopulos) "On December 23, we received FDA approval for narsoplimab now commercialized under the brand name YARTEMLEA" for TA-TMA, and Demopulos emphasized the label: "Specifically, no box warning, no risk evaluation and mitigation strategy or REMS program and no required vaccinations." (CEO Demopulos) Demopulos said commercialization started quickly: "Having supplied our distributors within the first 3 weeks of January, first sales occurred shortly thereafter." He also stated operational execution metrics: "Within 24 hours of placing an order, both adult and pediatric TA-TMA patients are now receiving YARTEMLEA." (CEO Demopulos) On early launch traction, management disclosed formulary penetration: YARTEMLEA was "now on formulary at 50% of the top 10 U.S. transplant centers, 40% of the top 20 centers, 35% of the top 40 centers and approximately 30% of the top 80 transplant centers." (CEO Demopulos) "This charge represents a noncash remeasurement adjustment and excluding it, provides a clearer view of the company's operating performance during the quarter." (VP of Finance, Chief Accounting Officer & Treasurer David Borges) Outlook Management said it is not providing near-term sales targets: "As YARTEMLEA is in the early stages of launch, we are not providing revenue guidance at this time." (Chief Accounting Officer Borges) Near-term expense trajec...